...Venture Partnership, Hangzhou Real Asset Management Fund, Fang Fund Partners and Chengdu Beiduojian. Existing investors Sangel Capital...
...LLC CG Oncology, Inc. Kissei Pharmaceutical Co. Ltd. ORI Healthcare Fund Perseverance Capital Management Denovo Biopharma LLC CICC Qide Yingke PE China Resources Pharmaceutical Sangel Capital Zheshang...

...series A round led by Korea Investment Partners with participation by Topping Capital, TigerYeah Capital, Sangel Capital...

...Lu, has STP705 in Phase II testing for non-melanoma skin cancer and hypertrophic scar reduction. Sangel Capital...
...Investment, and Lanshang Capital and previous investors Lucion Venture Capital, Shandong Transportation Development Fund and Sangel Capital...

...CICC Qide Fund, with participation by existing investors Jiuyou Capital, Share Capital, CITIC Securities and Sangel Capital...

...payment and is eligible for $100 million in milestones, plus royalties, according to Denovo investor Sangel Capital...

...2016 KBP BioSciences Co. Ltd. Jinan, China $76.0 Advantech Capital , SDIC Venture Capital , Sangel Capital...

...million Investors: 3SBio Inc., Sequoia China, 3E Bioventures, WuXi Healthcare Ventures, ShangBay Capital, Danhua Capital, Sangel Capital...

...round led by 3SBio Inc. (HKSE:1530) and Sequoia China. Fellow new investors Danhua Capital (DHVC), Sangel Capital...

...round led by 3SBio Inc. (HKSE:1530) and Sequoia China. Fellow new investors Danhua Capital (DHVC), Sangel Capital...

...round on Jan. 5 co-led by Advantech Capital and SDIC Venture Capital, with participation from Sangel Capital...